Improving the Quality and Understanding of Cancer Care
Over 15 years ago, the widely-publicized death of a healthcare reporter from a chemotherapy overdose at a leading cancer center sparked the creation of IntelliDose. Developed by oncologists for oncologists, IntelliDose® has become the leading clinical information system for medical oncology.
In practices ranging from single oncologist offices to major academic medical centers, IntelliDose improves patient safety, quality of care, and streamlines workflows. Oncologists use IntelliDose to manage and document every aspect of cancer care from treatment decisions to administration of drugs. This real-time information creates IntrinsiQ Data, an accurate, detailed, longitudinal clinical database of how cancer treatment is actually practiced and delivered.
Pharmaceutical companies, researchers, practicing oncologists, and other oncology stakeholders use IntrinsiQ to improve the quality and understanding of cancer care.
On September 6, 2011, AmerisourceBergen Corporation announced the acquisition of IntrinsiQ, LLC. IntrinsiQ is now part of AmerisourceBergen Specialty Group.
Learn more about the acquisition.
Learn more about AmerisourceBergen Corporation.